Infliximab + methotrexate (IFX + MTX)
P04422
Phase 3 small_molecule completed
Quick answer
Infliximab + methotrexate (IFX + MTX) for Arthritis, Psoriatic is a Phase 3 program (small_molecule) at INTEGRATED BIOPHARMA INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- INTEGRATED BIOPHARMA INC
- Indication
- Arthritis, Psoriatic
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed